Entresto 50 mg
Entresto 50 mg is a medicine authorised by Swissmedic under authorisation number 65673. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 September 2015 and the authorisation is valid without a time limit. ATC code C09DX04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 65673 |
|---|---|
| Name | Entresto 50 mg |
| Full name | Entresto 50 mg, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DX04 |
| First authorisation | 17 September 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Entresto 50 mg, Filmtabletten | B | 17 September 2015 |
| 2 | Entresto 100 mg, Filmtabletten | B | 17 September 2015 |
| 3 | Entresto 200 mg, Filmtabletten | B | 17 September 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 6 | 56 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 2 | 56 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 7 | 168 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 4 | 56 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 8 | 168 | Tablette(n) | C09DX04 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Entresto 50 mg authorised in Switzerland?
Yes. Entresto 50 mg is authorised by Swissmedic under authorisation number 65673, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Entresto 50 mg have?
Entresto 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Entresto 50 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.